Cargando…
P792: CRISPR/CAS9-BASED MODEL OF HETEROZYGOUS CXCR4 WT/R334X MUTATION TO STUDY CELLULAR PHENOTYPES IN WHIM SYNDROME
Autores principales: | Zmajkovicova, K., Pawar, S., Maier-Munsa, S., Badarau, A., Taveras, A. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429556/ http://dx.doi.org/10.1097/01.HS9.0000846052.61635.87 |
Ejemplares similares
-
Genotype–phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4(WHIM) variants
por: Zmajkovicova, Katarina, et al.
Publicado: (2022) -
P793: SCREENING OF NATURALLY OCCURRING CXCR4 VARIANTS FOR IDENTIFICATION OF NOVEL PATHOGENIC MUTATIONS FOR WHIM SYNDROME
por: Pawar, S., et al.
Publicado: (2022) -
AMD3100 is a potent antagonist at CXCR4(R334X), a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome
por: McDermott, David H, et al.
Publicado: (2011) -
Mesenchymal Stem/Stromal Cells Overexpressing CXCR4(R334X)
Revealed Enhanced Migration: A Lesson Learned from the Pathogenesis of WHIM
Syndrome
por: Bidkhori, Hamid Reza, et al.
Publicado: (2021) -
P1253: MAVORIXAFOR DISRUPTS THE CROSS TALK BETWEEN WALDENSTRÖM’S MACROGLOBULINEMIA CELLS AND THE BONE MARROW MICROENVIRONMENT RESULTING IN ENHANCED SENSITIVITY TO B-CELL TARGETED THERAPIES
por: Monticelli, H., et al.
Publicado: (2022)